Dimethocaine
DMC, CMD, Larocaine
Stimulant, Research-chemical, Habit-forming, Tentative
Dimethocaine is a synthetic cocaine-derived local anesthetic with stimulant properties. It acts primarily as a dopamine reuptake inhibitor and voltage-gated sodium channel blocker, producing cocaine-like but generally less intense effects. Despite being perceived as milder, it carries substantial cardiovascular and tissue toxicity risks. Metabolism is dominated by NAT2-mediated N-acetylation, with additional contributions from multiple cytochrome P450 enzymes, resulting in significant inter-individual variability and elevated risk for slow acetylators.
Note: Dimethocaine shows strong inter-individual variability due to NAT2 polymorphism. Redosing and high doses substantially increase cardiovascular and tissue toxicity risk.
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Strong
Insufflated
5-15mg
15-30mg
30-50mg
Onset
Duration
After Effects
Insufflated
2m to 10m
1h 30m to 3
1 to 6
Stimulation, Euphoria, Increased alertness, Local numbness, Increased confidence, Tachycardia (increased heart rate), Vasoconstriction, Increased blood pressure, Anxiety, Jaw tension, Insomnia
Wikipedia contributors. Dimethocaine. Wikipedia, The Free Encyclopedia. https://en.wikipedia.org/wiki/DimethocaineLindauer C. Toxicokinetics of Emerging Drugs of Abuse: In vivo and in vitro studies on the metabolic fate of the cocaine-derived designer drug dimethocaine. Universität des Saarlandes, 2014. https://jahrbib.sulb.uni-saarland.de/bitstream/20.500.11880/21949/1/Dissertation_Lindauer_Dimethocaine_final_hhm.pdfMeyer MR, Lindauer C, Maurer HH. Dimethocaine, a synthetic cocaine derivative: Studies on its in vitro metabolism catalyzed by P450s and NAT2. Toxicology Letters. 2014;225(1):139–146. https://doi.org/10.1016/j.toxlet.2013.11.033